186 related articles for article (PubMed ID: 18155779)
1. Differential effects of decoy chemokine (7ND) gene therapy on acute, biphasic and chronic autoimmune encephalomyelitis: implication for pathomechanisms of lesion formation.
Park IK; Hiraki K; Kohyama K; Matsumoto Y
J Neuroimmunol; 2008 Feb; 194(1-2):34-43. PubMed ID: 18155779
[TBL] [Abstract][Full Text] [Related]
2. Characterization of relapsing autoimmune encephalomyelitis and its treatment with decoy chemokine receptor genes.
Matsumo Y; Sakuma H; Miyakoshi A; Tsukada Y; Kohyama K; Park IK; Tanuma N
J Neuroimmunol; 2005 Dec; 170(1-2):49-61. PubMed ID: 16223531
[TBL] [Abstract][Full Text] [Related]
3. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Berard JL; Wolak K; Fournier S; David S
Glia; 2010 Mar; 58(4):434-45. PubMed ID: 19780195
[TBL] [Abstract][Full Text] [Related]
4. Macrophage apoptosis in the central nervous system in experimental autoimmune encephalomyelitis.
Nguyen KB; McCombe PA; Pender MP
J Autoimmun; 1994 Apr; 7(2):145-52. PubMed ID: 8037835
[TBL] [Abstract][Full Text] [Related]
5. Characterization of CD8-positive macrophages infiltrating the central nervous system of rats with chronic autoimmune encephalomyelitis.
Hiraki K; Park IK; Kohyama K; Matsumoto Y
J Neurosci Res; 2009 Apr; 87(5):1175-84. PubMed ID: 18951531
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.
Begolka WS; Vanderlugt CL; Rahbe SM; Miller SD
J Immunol; 1998 Oct; 161(8):4437-46. PubMed ID: 9780223
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological study of a myelin oligodendrocyte glycoprotein-induced demyelinating disease in LEW.1AV1 rats.
Sakuma H; Kohyama K; Park IK; Miyakoshi A; Tanuma N; Matsumoto Y
Brain; 2004 Oct; 127(Pt 10):2201-13. PubMed ID: 15282218
[TBL] [Abstract][Full Text] [Related]
8. In situ demonstration of proliferating cells in the rat central nervous system during experimental autoimmune encephalomyelitis. Evidence suggesting that most infiltrating T cells do not proliferate in the target organ.
Ohmori K; Hong Y; Fujiwara M; Matsumoto Y
Lab Invest; 1992 Jan; 66(1):54-62. PubMed ID: 1731149
[TBL] [Abstract][Full Text] [Related]
9. Anti-T cell monoclonal antibodies in vivo. II. Modulation of acute and chronic experimental allergic encephalomyelitis (EAE) in guinea pigs.
Sobel RA; Blanchette BW; Russo MA; Williams AM; Colvin RB
J Immunol; 1987 Apr; 138(8):2507-13. PubMed ID: 3494072
[TBL] [Abstract][Full Text] [Related]
10. Surgical excision of CNS-draining lymph nodes reduces relapse severity in chronic-relapsing experimental autoimmune encephalomyelitis.
van Zwam M; Huizinga R; Heijmans N; van Meurs M; Wierenga-Wolf AF; Melief MJ; Hintzen RQ; 't Hart BA; Amor S; Boven LA; Laman JD
J Pathol; 2009 Mar; 217(4):543-51. PubMed ID: 19023878
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic activity of malononitrilamides (MNA 279 and MNA 715) on acute and chronic, relapsing, experimental, allergic encephalomyelitis (EAE).
Schorlemmer HU; Bartlett RR
Drugs Exp Clin Res; 1997; 23(5-6):175-81. PubMed ID: 9515227
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of monocyte chemotactic protein-1 and CC chemokine receptor 2 in the central nervous system is closely associated with relapse of autoimmune encephalomyelitis in Lewis rats.
Jee Y; Yoon WK; Okura Y; Tanuma N; Matsumoto Y
J Neuroimmunol; 2002 Jul; 128(1-2):49-57. PubMed ID: 12098510
[TBL] [Abstract][Full Text] [Related]
13. A pathogenic role for gamma delta T cells in relapsing-remitting experimental allergic encephalomyelitis in the SJL mouse.
Rajan AJ; Gao YL; Raine CS; Brosnan CF
J Immunol; 1996 Jul; 157(2):941-9. PubMed ID: 8752949
[TBL] [Abstract][Full Text] [Related]
14. The role of macrophages, perivascular cells, and microglial cells in the pathogenesis of experimental autoimmune encephalomyelitis.
Bauer J; Huitinga I; Zhao W; Lassmann H; Hickey WF; Dijkstra CD
Glia; 1995 Dec; 15(4):437-46. PubMed ID: 8926037
[TBL] [Abstract][Full Text] [Related]
15. Phagocytic activity of macrophages and microglial cells during the course of acute and chronic relapsing experimental autoimmune encephalomyelitis.
Bauer J; Sminia T; Wouterlood FG; Dijkstra CD
J Neurosci Res; 1994 Jul; 38(4):365-75. PubMed ID: 7932870
[TBL] [Abstract][Full Text] [Related]
16. High IL-6 and low IL-10 in the central nervous system are associated with protracted relapsing EAE in DA rats.
Diab A; Zhu J; Xiao BG; Mustafa M; Link H
J Neuropathol Exp Neurol; 1997 Jun; 56(6):641-50. PubMed ID: 9184655
[TBL] [Abstract][Full Text] [Related]
17. Ribavirin reduces clinical signs and pathological changes of experimental autoimmune encephalomyelitis in Dark Agouti rats.
Milicevic I; Pekovic S; Subasic S; Mostarica-Stojkovic M; Stosic-Grujicic S; Medic-Mijacevic L; Pejanovic V; Rakic L; Stojiljkovic M
J Neurosci Res; 2003 Apr; 72(2):268-78. PubMed ID: 12672002
[TBL] [Abstract][Full Text] [Related]
18. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE).
Olechowski CJ; Truong JJ; Kerr BJ
Pain; 2009 Jan; 141(1-2):156-64. PubMed ID: 19084337
[TBL] [Abstract][Full Text] [Related]
19. Early macrophage MRI of inflammatory lesions predicts lesion severity and disease development in relapsing EAE.
Brochet B; Deloire MS; Touil T; Anne O; Caillé JM; Dousset V; Petry KG
Neuroimage; 2006 Aug; 32(1):266-74. PubMed ID: 16650776
[TBL] [Abstract][Full Text] [Related]
20. Treatment with anti-CR3 antibodies ED7 and ED8 suppresses experimental allergic encephalomyelitis in Lewis rats.
Huitinga I; Damoiseaux JG; Döpp EA; Dijkstra CD
Eur J Immunol; 1993 Mar; 23(3):709-15. PubMed ID: 8449218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
